o.vukovic
TL2 Moderator · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 12 July 2025 · last posted 5d · groups: newcomer-guides
87 posts, newest first. Showing up to 150.
-
The most useful thing you learned here that was not the answer you came for Replied, post #61 · Lounge › Off topic · 23 Jul 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What a certificate commits its issuer to Replied, post #87 · Analytics › COA interpretation · 23 Jul 2026 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Does a peptide degrade silently, with no visual change? Replied, post #68 · Practice › Storage & stability · 11 Jul 2026 · 20 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #23 · Practice › Interactions · 8 Jul 2026 · 27 likes This follows post #20 rather than contradicting it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others…
-
The headache that turns out to be dehydration — the long version Replied, post #62 · Nutrition & Training › Hydration & electrolytes · 6 Jul 2026 · 3 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #35 · Analytics › Home & field testing · 28 Jun 2026 · 2 likes Picking up post #32: that is the part I would want checked first. Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody…
-
Sleep quality changes during weight loss Replied, post #3 · Wellbeing › Sleep · 26 Jun 2026 · 8 likes post #2 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #17 · Practice › Dosing & titration · 25 Jun 2026 · 19 likes On post #13 — agreed on the reasoning, with one qualification. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #56 · Compounds › Tirzepatide · 24 Jun 2026 · 15 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #10 · Nutrition & Training › Protein & intake · 18 Jun 2026 · 0 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #43 · Start Here › How to Ask · 15 Jun 2026 · 1 like Picking up post #40: that is the part I would want checked first. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room…
-
Cold solution and stinging: the simplest fix Replied, post #35 · Practice › Administration · 14 Jun 2026 · 1 like On post #31 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #6 · Lounge › Off topic · 12 Jun 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #25 · Practice › Reconstitution · 10 Jun 2026 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Constipation management, with a dietitian's contribution Replied, post #74 · Practice › Side effects · 4 Jun 2026 · 30 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #3 · Sourcing › Red flags · 2 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #20 · Practice › Reconstitution · 28 May 2026 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Step therapy requirements and how to satisfy them Replied, post #24 · Access › Insurance & coverage · 24 May 2026 · 18 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #3 · Pharmacology › Receptor biology · 23 May 2026 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The best-written scientific paper you have read Replied, post #40 · Lounge › Off topic · 10 May 2026 · 23 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #36 · Practice › Reconstitution · 3 May 2026 · 32 likes post #35 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
GLP-1 receptor distribution: central and peripheral Replied, post #40 · Pharmacology › Receptor biology · 29 Apr 2026 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #121 · Pharmacology › Pharmacokinetics · 27 Apr 2026 · 18 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #15 · Lounge › Introductions · 26 Apr 2026 · 15 likes post #14 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #33 · Sourcing › Red flags · 19 Apr 2026 · 1 like Picking up post #30: that is the part I would want checked first. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact…
-
[2026 update] What a purity-only report leaves out Replied, post #85 · Sourcing › Independent verification · 10 Apr 2026 · 13 likes Worth separating two things that post #81 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #55 · Outcomes › Body composition · 8 Apr 2026 · 9 likes Worth separating two things that post #51 runs together. Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #42 · Practice › Administration · 4 Apr 2026 · 25 likes post #41 answers the question as asked. The question underneath it is different. Cold solution and stinging: warming the vial in your hands for a minute before…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #68 · Compounds › Tirzepatide · 3 Apr 2026 · 10 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
What a documentation review can and cannot tell you — a second dataset Replied, post #4 · Sourcing › Independent verification · 2 Apr 2026 · 9 likes the opening post is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #88 · Research Methods › N-of-1 designs · 21 Mar 2026 · 21 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #58 · Research Methods › Statistics · 21 Mar 2026 · 2 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #44 · Access › International · 20 Mar 2026 · 14 likes On post #40 — agreed on the reasoning, with one qualification. Customs and import outcomes: different routes have different seizure rates. Some countries are stricter…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #63 · Research Methods › N-of-1 designs · 14 Mar 2026 · 23 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Second pass at: Identical chromatograms across two different lots Replied, post #50 · Sourcing › Red flags · 8 Mar 2026 · 8 likes On post #46 — agreed on the reasoning, with one qualification. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and…
-
The lowest dose that does anything: is that a real question? Replied, post #20 · Practice › Dosing & titration · 2 Mar 2026 · 3 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Personal import allowances, compared — a second dataset Replied, post #69 · Access › International · 15 Feb 2026 · 1 like Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Trifluoroacetate content and its consequences Replied, post #116 · Analytics › Impurities & related substances · 9 Feb 2026 · 11 likes post #115 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #10 · Start Here › Welcome · 7 Feb 2026 · 3 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Second pass at: What to keep a record of at the point of payment Replied, post #6 · Sourcing › Payments · 30 Jan 2026 · 31 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #134 · Documentation › Doc review · 17 Jan 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #34 · Clinical › Bloodwork · 10 Jan 2026 · 6 likes Coming back to post #32, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #105 · Analytics › COA interpretation · 6 Jan 2026 · 14 likes post #104 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #26 · Documentation › Wiki requests · 6 Jan 2026 · 30 likes post #25 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
MHRA statements, read directly Replied, post #44 · Regional › UK & Ireland · 7 Dec 2025 · 0 likes Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines…
-
[2026 update] What steady state means for the decision to escalate Replied, post #63 · Practice › Dosing & titration · 11 Nov 2025 · 7 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #10 · Access › Pricing · 4 Nov 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Batch date after test date, and other internal inconsistencies Replied, post #13 · Analytics › COA interpretation · 31 Oct 2025 · 4 likes post #12 is right about the mechanism and I think understates the practical bit. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Documentation that appears only after payment Replied, post #63 · Sourcing › Red flags · 31 Oct 2025 · 14 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #32 · Start Here › How to Ask · 27 Oct 2025 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #75 · Compounds › Semaglutide · 14 Oct 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Reading SURMOUNT-1 without the press release Replied, post #29 · Compounds › Tirzepatide · 9 Oct 2025 · 2 likes Picking up post #26: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
Revisiting: German, French and Dutch differences, compared Replied, post #78 · Regional › European Union · 26 Sep 2025 · 27 likes Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #75 · Practice › Side effects · 19 Sep 2025 · 5 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
How to read a forest plot, properly, from scratch Replied, post #18 · Evidence › Trials · 21 Aug 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A request that was declined, and the reasoning — a second dataset Replied, post #41 · Documentation › Wiki requests · 10 Aug 2025 · 13 likes Coming back to post #39, because the follow-up matters more than the original answer. Translation suggestions: if a maintained page should exist in another language,…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #74 · Data & Tools › Calculators · 6 Aug 2025 · 2 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Sodium, potassium and magnesium when intake drops Replied, post #51 · Nutrition & Training › Hydration & electrolytes · 9 Jul 2025 · 2 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #119 · Clinical › Comorbidities · 19 Jun 2025 · 24 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #27 · Clinical › Bloodwork · 30 May 2025 · 4 likes post #26 is right about the mechanism and I think understates the practical bit. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
Half-life, steady state, and accumulation worked through Started this topic · Pharmacology › Pharmacokinetics · 18 May 2025 · 0 likes Half-life, steady state, and accumulation worked through Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity…
-
Metformin co-administration and additive GI effects Replied, post #5 · Practice › Interactions · 20 Apr 2025 · 5 likes Worth separating two things that the opening post runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be…
-
Validating a method you did not develop — does this still hold? Replied, post #113 · Analytics › Method validation · 14 Mar 2025 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #50 · Compounds › Secretagogues & GH axis · 12 Mar 2025 · 0 likes post #49 is right about the mechanism and I think understates the practical bit. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #51 · Sourcing › Regulatory · 1 Mar 2025 · 19 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Consistent declarations and why they matter more than clever ones Replied, post #81 · Sourcing › Logistics · 24 Feb 2025 · 17 likes Worth separating two things that post #77 runs together. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing…
-
Consistent declarations and why they matter more than clever ones Replied, post #62 · Sourcing › Logistics · 21 Feb 2025 · 1 like Picking up post #59: that is the part I would want checked first. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before…
-
Coming back to: Official shortage notices and what they authorise Replied, post #19 · Access › Shortages · 15 Feb 2025 · 1 like Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #150 · Clinical › Prescriber conversations · 18 Jan 2025 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Follow-up: Individual participant data versus aggregate data Replied, post #51 · Evidence › Meta-analyses · 10 Jan 2025 · 10 likes This follows post #48 rather than contradicting it. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies…
-
Reading a supplementary appendix and finding the interesting part Replied, post #61 · Evidence › Trials · 6 Jan 2025 · 0 likes I read post #59 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a…
-
Body image changing more slowly than the body Replied, post #86 · Wellbeing › Mental health · 20 Dec 2024 · 30 likes post #85 answers the question as asked. The question underneath it is different. Motivation and expectation: starting with clear motivation and realistic expectations…
-
Fibre intake when total intake falls, and the constipation link Replied, post #8 · Nutrition & Training › Protein & intake · 18 Dec 2024 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
When "no data" is the complete and final answer Replied, post #39 · Compounds › Other compounds · 11 Dec 2024 · 16 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
[2026 update] New subcategory: rationale and scope Replied, post #45 · Meta › Announcements · 6 Dec 2024 · 29 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
Fixed versus detachable needles: the trade-offs Replied, post #30 · Devices › Syringes & needles · 3 Dec 2024 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
-
EMA product information as a primary source — does this still hold? Replied, post #114 · Regional › European Union · 18 Nov 2024 · 13 likes This follows post #111 rather than contradicting it. EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU,…
-
EMA product information as a primary source — does this still hold? Replied, post #86 · Regional › European Union · 17 Nov 2024 · 0 likes post #85 answers the question as asked. The question underneath it is different. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands)…
-
When to suspect the method rather than the sample Replied, post #34 · Analytics › Method validation · 8 Nov 2024 · 1 like Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #11 · Compounds › Tirzepatide · 27 Oct 2024 · 12 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #10 · Sourcing › Regulatory · 20 Oct 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #44 · Compounds › Other compounds · 11 Oct 2024 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
The topic list is dense — is that deliberate? Replied, post #35 · Meta › Site feedback · 7 Oct 2024 · 10 likes Search and findability: if you searched for something and did not find it, report what you searched for and what you expected to find. That helps improve indexing and…
-
Why a preprint's supplementary material is often the best part Replied, post #32 · Evidence › Preprints · 21 Sep 2024 · 18 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #43 · Sourcing › Independent verification · 8 Sep 2024 · 7 likes This follows post #40 rather than contradicting it. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued…
-
Guidelines revision: what changed and why Replied, post #31 · Meta › Announcements · 25 Jul 2024 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #36 · Practice › Dosing & titration · 1 Jul 2024 · 5 likes This follows post #33 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…